Cargando…
Early administration of remdesivir to COVID-19 patients associates with higher recovery rate and lower need for ICU admission: A retrospective cohort study
OBJECTIVES: Remdesivir is one of the most widely recommended and used medications for COVID-19 treatment. However, different outcomes have been reported for hospitalized patients with COVID-19 treated with remdesivir. Specifically, the effect of the timing of remdesivir initiation (from patient’s sy...
Autores principales: | Hussain Alsayed, Hawra Ali, Saheb Sharif-Askari, Fatemeh, Saheb Sharif-Askari, Narjes, Hussain, Ali Al Sayed, Hamid, Qutayba, Halwani, Rabih |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8547637/ https://www.ncbi.nlm.nih.gov/pubmed/34699552 http://dx.doi.org/10.1371/journal.pone.0258643 |
Ejemplares similares
-
Upregulation of oxidative stress gene markers during SARS-COV-2 viral infection
por: Saheb Sharif-Askari, Narjes, et al.
Publicado: (2021) -
Vitamin D enhances type I IFN signaling in COVID-19 patients
por: Hafezi, Shirin, et al.
Publicado: (2022) -
Upregulation of interleukin-19 in saliva of patients with COVID-19
por: Saheb Sharif-Askari, Fatemeh, et al.
Publicado: (2022) -
Airways tissue expression of type I interferons and their stimulated genes is higher in children than adults
por: Saheb Sharif-Askari, Narjes, et al.
Publicado: (2022) -
Interleukin-17, a salivary biomarker for COVID-19 severity
por: Sharif-Askari, Fatemeh Saheb, et al.
Publicado: (2022)